CorMedix
CRMD
#6107
Rank
A$1.37 B
Marketcap
A$17.50
Share price
3.20%
Change (1 day)
19.77%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): A$0.16 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$29.11 Million, an increase over its 2023 earnings that were of -A$69.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.16 B-667.63%
2024 -A$29.11 Million-58.3%
2023 -A$69.79 Million53%
2022 -A$45.61 Million2.81%
2021 -A$44.37 Million8.32%
2020 -A$40.96 Million26.53%
2019 -A$32.37 Million-19.89%
2018 -A$40.41 Million-18.72%
2017 -A$49.71 Million34.56%
2016 -A$36.95 Million34.88%
2015 -A$27.39 Million-11.08%
2014 -A$30.81 Million124.69%
2013 -A$13.71 Million144.91%
2012 -A$5.6 Million-48.41%
2011 -A$10.86 Million-33.29%
2010 -A$16.27 Million78.42%
2009 -A$9.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.84 B 1,662.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$23.32 M-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA